🔊 CEOInterviews
Start App
CEO / Investor / Company ⓘ
Topic or Keyword ⓘ
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Joseph Wolk

Executive VP & CFO, Johnson Johnson

Search every verified Joseph Wolk interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Joseph Wolk, Executive Vice President and CFO of Johnson & Johnson, discussed the company's second-quarter 2026 earnings in a July 16, 2026 interview. He noted that three out of four units in the medical technology division performed well, including surgery, orthopedics, and vision care, while heart pump revenue saw a 2% decline in U.S. demand. Wolk highlighted strong pharmaceutical sales, particularly for the drug Tremfya, which he said had become a standard of care for colitis and Crohn's disease with 71% growth. He attributed the company's $55 billion U.S. investment plan through early 2029 to favorable tax policy and the U.S. innovation ecosystem, stating that "the best talent is here" and that Johnson & Johnson, as an American-based company, wants to invest in the U.S. During the company's first-quarter 2026 earnings call on April 1, 2026, Wolk reported that Johnson & Johnson had invested roughly $12 billion of the $55 billion U.S. plan by the end of 2025, with significant investment continuing in 2026. He raised the full-year 2026 operational sales guidance to a range of 5.9% to 6.9% growth, with a midpoint of $100.2 billion, and increased adjusted earnings per share guidance to $11.30 to $11.50. Wolk stated that the company's strategy in medical technology, focused on cardiovascular, vision, and surgery, was working, and that Q1 unfolded as expected despite a dynamic market. He also noted that free cash flow in Q1 was approximately $1.5 billion, below the full-year projection due to timing changes in rebate programs and increased capital expenditures, but expressed confidence in the full-year outlook.

Selected quotes

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →